Amlodipine Besylate is a long-acting dihydropyridine calcium channel blocker that relaxes vascular smooth muscle, making it one of the most widely prescribed first-line therapies for hypertension and chronic stable angina. Simson Pharma's Amlodipine Besylate reference standard and impurities support the high-volume compendial and stability-indicating testing this globally significant generic demands.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Amlodipine Besylate Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.